Delivery Order SPE2DB20D1004-SPE2DB24FF2U8
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,148.54 and is for the supply of the pharmaceutical drug GILENYA 0.5 MG CAPSULE 30S. The contract is a firm fixed-price agreement with a period of performance through November 22, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $16,605.92 Firm Fixed Price Delivery Order is for the supply of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of July 19, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GILENYA 0.5 MG CAPSULE 30S, a specialty pharmaceutical product, with a ceiling value of $6,158.65 and a period of performance through March 26, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside program....
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4557723651 GILENYA 0.5 MG CAPSULE UU 30S. The award has a ceiling value of $33,979.99 and a performance period ending on July 7, 2022. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,806.32, is for the delivery of GILENYA 0.5 MG CAPSULE 30S medication. The contract has an ultimate completion date of November 14, 2023 and is a Firm Fixed Price Delivery Order. There was no set-aside designation for this contract award. AmerisourceBergen holds a significant Indefinite...
- This federal contract award, valued at $12,163.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical, which runs through November 2026. The contract is for the supply of GILENYA 0.5 MG CAPSULE 30S, a prescription medication. It has a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GILENYA 0.5 MG CAPSULE 30S, a prescription medication, with a ceiling value of $11,603.06 and a period of performance through October 2024. The contract is not designated as a set-aside and is a firm fixed-price arrangement. It is associated with a larger Indefinite Delivery...
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,556,764,359 units of the medication GILENYA 0.5 MG CAPSULE. The $18,358.08 firm fixed-price delivery order has an ultimate completion date of April 4, 2022. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award, with ID SPE2DB20D1004|SPE2DB24FF9U2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,555.59, is a delivery order for the supply of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of May 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a federal delivery order award to AmerisourceBergen Drug Corp for the provision of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $48,828.20. The award is under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB24FF2U8Delivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,600.70 and an ultimate completion date of January 25, 2024. The contract is for the provision of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award did not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 1/24/24 |